AIMS: Pleomorphic adenoma gene 1 (PLAG1) rearrangement is well known in pleomorphic adenoma (PA), which is histologically characterised by admixed epithelial and mesenchymal components. Multiple fusion variants of PLAG1 and HMGA2 have been reported; currently, however, little is known regarding the clinicopathological impacts of these fusion types METHODS AND RESULTS: We examined the PLAG1- and HMGA2-related fusion status in 105 PAs and 11 cases of carcinoma ex PAs (CXPA) arising from salivary glands and lacrimal glands to elucidate their correlation to the clinicopathological factors. Forty cases harboured PLAG1 fusion genes: CTNNB1-PLAG1 in 22 cases, CHCHD7-PLAG1 in 14 cases and LIFR-PLAG1 in four cases. Only two cases possessed HMGA2 fusion genes. The mean age of LIFR-PLAG1-positive cases was significantly higher than that of CTNNB1-PLAG1- and CHCHD7-PLAG1-positive cases (P = 0.0358). PAs located in the submandibular gland demonstrated CTNNB1-PLAG1 fusion at a significantly higher rate than other fusions (P = 0.0109). Histologically, PLAG1 fusion-positive cases exhibited chondroid formation and plasmacytoid features more commonly (P = 0.043, P = 0.015, respectively) and myxoid abundant feature less frequently (P = 0.031) than PLAG1 fusion-negative cases. For CXPAs, four CTNNB1-PLAG1 fusions were detected in two salivary duct carcinomas and two myoepithelial carcinomas. Ductal formation was observed frequently (90.9%) in residual PA. CONCLUSIONS: The presence of PLAG1 fusion was associated with specific histological features in PA. Detecting the PLAG1 fusion gene and searching residual ductal formation in salivary gland malignant tumours with extensive hyalinisation could be useful for diagnosis.
AIMS: Pleomorphic adenoma gene 1 (PLAG1) rearrangement is well known in pleomorphic adenoma (PA), which is histologically characterised by admixed epithelial and mesenchymal components. Multiple fusion variants of PLAG1 and HMGA2 have been reported; currently, however, little is known regarding the clinicopathological impacts of these fusion types METHODS AND RESULTS: We examined the PLAG1- and HMGA2-related fusion status in 105 PAs and 11 cases of carcinoma ex PAs (CXPA) arising from salivary glands and lacrimal glands to elucidate their correlation to the clinicopathological factors. Forty cases harboured PLAG1 fusion genes: CTNNB1-PLAG1 in 22 cases, CHCHD7-PLAG1 in 14 cases and LIFR-PLAG1 in four cases. Only two cases possessed HMGA2 fusion genes. The mean age of LIFR-PLAG1-positive cases was significantly higher than that of CTNNB1-PLAG1- and CHCHD7-PLAG1-positive cases (P = 0.0358). PAs located in the submandibular gland demonstrated CTNNB1-PLAG1 fusion at a significantly higher rate than other fusions (P = 0.0109). Histologically, PLAG1 fusion-positive cases exhibited chondroid formation and plasmacytoid features more commonly (P = 0.043, P = 0.015, respectively) and myxoid abundant feature less frequently (P = 0.031) than PLAG1 fusion-negative cases. For CXPAs, four CTNNB1-PLAG1 fusions were detected in two salivary duct carcinomas and two myoepithelial carcinomas. Ductal formation was observed frequently (90.9%) in residual PA. CONCLUSIONS: The presence of PLAG1 fusion was associated with specific histological features in PA. Detecting the PLAG1 fusion gene and searching residual ductal formation in salivary gland malignant tumours with extensive hyalinisation could be useful for diagnosis.
Authors: Fresia Pareja; Arnaud Da Cruz Paula; Rodrigo Gularte-Mérida; Mahsa Vahdatinia; Anqi Li; Felipe C Geyer; Edaise M da Silva; Gouri Nanjangud; Hannah Y Wen; Zsuzsanna Varga; Edi Brogi; Emad A Rakha; Britta Weigelt; Jorge S Reis-Filho Journal: NPJ Breast Cancer Date: 2020-06-05
Authors: Adepitan A Owosho; Olufunlola M Adesina; Oluwole Odujoko; Hezekiah Akinyemi; Akinwumi Komolafe; Simon Tadros; Robert Bauer; Kurt F Summersgill Journal: Int J Clin Exp Pathol Date: 2022-02-15
Authors: Karen Fritchie; Lu Wang; Zhaohong Yin; Joy Nakitandwe; Dale Hedges; Andrew Horvai; Jorge Torres Mora; Andrew L Folpe; Armita Bahrami Journal: Mod Pathol Date: 2020-10-23 Impact factor: 7.842
Authors: Catherine T Chung; Cristina R Antonescu; Brendan C Dickson; Rose Chami; Paula Marrano; Rong Fan; Mary Shago; Meera Hameed; Paul S Thorner Journal: Genes Chromosomes Cancer Date: 2020-12-30 Impact factor: 5.006
Authors: Niels J Rupp; Sylvia Höller; Muriel Brada; Domenic Vital; Grégoire B Morand; Martina A Broglie; Martin W Huellner; Sandra N Freiberger Journal: Genes Chromosomes Cancer Date: 2021-11-17 Impact factor: 4.263
Authors: Fresia Pareja; Arnaud Da Cruz Paula; Rodrigo Gularte-Mérida; Mahsa Vahdatinia; Anqi Li; Felipe C Geyer; Edaise M da Silva; Gouri Nanjangud; Hannah Y Wen; Zsuzsanna Varga; Edi Brogi; Emad A Rakha; Britta Weigelt; Jorge S Reis-Filho Journal: NPJ Breast Cancer Date: 2020-06-05
Authors: Justin Bubola; Christina M MacMillan; Elizabeth G Demicco; Rose A Chami; Catherine T-S Chung; Iona Leong; Paula Marrano; Zeynep Onkal; David Swanson; Brandon M Veremis; Ilan Weinreb; Lei Zhang; Cristina R Antonescu; Brendan C Dickson Journal: Genes Chromosomes Cancer Date: 2021-07-08 Impact factor: 4.263